| # | Drug | Count |
|---|---|---|
| 0 | MAVACAMTEN | 55 |
| 1 | METOPROLOL | 18 |
| 2 | METOPROLOL TARTRATE | 18 |
| 3 | ACETAMINOPHEN | 15 |
| 4 | METOPROLOL TARTRATE INJECTION | 15 |
| 5 | ERGOCALCIFEROL | 14 |
| 6 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 12 |
| 7 | ALBUTEROL | 12 |
| 8 | ALBUTEROL SULFATE | 12 |
| 9 | ROSUVASTATIN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AFICAMTEN | 7 | 0.0141 |
| 1 | HISTAMINE | 2 | 0.0138 |
| 2 | MAVACAMTEN | 55 | 0.0091 |
| 3 | 2%MENTHOL | 1 | 0.0010 |
| 4 | COUGH SUPPRESSANT | 1 | 0.0010 |
| 5 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 6 | ERGOCALCIFEROL | 14 | 0.0005 |
| 7 | BEMPEDOIC ACID | 1 | 0.0004 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 9 | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Cardiac Myosin Inhibitor [EPC] | 55 |
| 1 | Vitamin C [EPC] | 15 |
| 2 | Provitamin D2 Compound [EPC] | 14 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 13 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 12 |
| 6 | Expectorant [EPC] | 12 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 11 |
| 8 | Calcium Channel Blocker [EPC] | 11 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cardiac Myosin Inhibitor [EPC] | 55 | 0.0091 |
| 1 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 2 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 4 | Aluminum Complex [EPC] | 2 | 0.0001 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 2 | 0.0001 |
| 6 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 7 | Expectorant [EPC] | 12 | 0.0001 |
| 8 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 4 | 0.0000 |